Analyzing incidence of testis cancer by means of a frailty model

Cancer Causes and Control

Volumn 10, Issue 4, 1999, Pages 285-292

  Aalen, Odd O ^a   Tretli, Steinar ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Environmental cause; Fetal life; Frailty; Norway; Susceptibility; Testicular cancer

Indexed keywords

AGE; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER SUSCEPTIBILITY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL MODEL; TESTIS CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; DISEASE SUSCEPTIBILITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; NORWAY; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0032786930     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008916718152     Document Type: Article

References (23)

1. Wanderås EH, Tretli S, Fosså SD (1995) Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer 31A: 2044-2048.
2. Henderson BE, Ross R, Bernstein L (1988) Estrogens as a cause of human cancer the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 48: 246-253.
3. Swerdlow AJ (1997) Epidemiology of testicular cancer. In: Raghavan D, Scher HI, Leibel SA, Lange D, eds. Principles and Practice of Genitourinary Oncology. New York: Lippincott-Raven, pp. 643-652.
4. Hougaard P (1984) Life table methods for heterogeneous populations: distributions describing the heterogeneity. Biometrika 71: 75-83.
5. Aalen OO (1988) Heterogeneity in survival analysis. Stat Med 7: 1121-1137.
6. Aalen OO (1994) Effects of frailty in survival analysis. Stat Methods Med Res 3: 227-243.
7. Aalen OO (1992) Modelling heterogeneity in survival analysis by the compound Poisson distribution. Ann Appl Probab 2: 951-972.
8. Armitage P, Doll R (1954) The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8: 1-15.
9. Day NE, Brown CC (1980) Multistage models and primary prevention of cancer. J Natl Cancer Inst 64: 977-989.
10. Jørgensen N, Giwercman A, Müller J, Skakkebaek NE (1993) Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells. Histopathalogy 22: 373-378.
11. Fahrmeir L, Tutz G (1994) Multivariate Statistical Modelling Based on Generalized Linear Models. New York: Springer-Verlag.
12. Wanderås EH, Grotmol T, Fosså SD, Tretli S (1998) Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 9: 475-486.
13. Aakre O, Ekbom A, Hsieh CC, Trichopoulos D, Adami HO (1996) Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst 88: 883-889.
14. IARC (1987) Overall Evaluations of Carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. Lyon: IARC Monographs, Suppl. 7: 273-76.
15. von der Maase H, Röhrt M, Walbom Jörgensen S, et al. (1986) Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J Clin Res Ed 293: 1398-1401.
16. Giwercman A, Bruun E, Frimodt Möller C, Skakkebaek NE (1989) Prevalence or carcinoma in situ and other histopathological abnormalities in testis with a history of cryptorchidism. J Urol 142: 998-1001.
17. Loy V, Wigland I, Dieckmann KP (1990) Incidence and distribution of carcinoma in situ in testis removed for germ cell tumor: possible inadequacy of random testicular biopsy in detecting the condition. Histopathology 16: 198-200.
18. Møller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23; 8-15.
19. Giwercman A, Müller J, Skakkebaek NE (1991) Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 145: 77-80.
20. Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen A-L, Fosså SD (1996) Familial testicular cancer in Norway and Southern Sweden. Br J Cancer 73: 964-969.
21. Aalen OO (1991) Modelling the influence of risk factors on familial aggregation of disease. Biometrics 47: 933-945.
22. Khoury J.M., Beaty T.H., Liang K.Y (1988) Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 127: 674-683.
23. Heimdal K, Olsson H, Tretli S, Fosså SD, Borresen AL, Bishop DT (1997) A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer 75: 1084-1087.